Ritedose, owned by AGIC and Humanwell, readies William Blair sale process

Less than four years after buying the pharmaceutical business from Olympus Partners, Ritedose's owners, based in China and Europe, could fetch some $1.5bn in a potential transaction.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this